T B Lund1, M E J Nielsen2, P Sandøe3. 1. Department of Food and Resource Economics, University of Copenhagen, Copenhagen, Denmark. 2. Department of Media, Cognition and Communication, Department of Food and Resource Economics, University of Copenhagen, Copenhagen, Denmark. 3. 1] Department of Food and Resource Economics, University of Copenhagen, Copenhagen, Denmark [2] Department of Large Animal Sciences University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND/ OBJECTIVES: This study examined public support for publicly funded treatment of obesity (weight-loss surgery and medical treatment) and two pulmonary diseases (chronic obstructive pulmonary disease (COPD) and lung cancer) in Denmark. It also investigated whether beliefs about the causes of lifestyle-related diseases (external environment, genetic disposition and lack of willpower) and agreement that 'people lack responsibility for their life and welfare' influenced support. SUBJECTS/ METHODS: This was a questionnaire study in which a sample of 1003 Danes (age 18-65 years) drawn from an Internet database were surveyed. RESULTS: Approximately one in three supported publicly funded weight-loss surgery (30%) and medical treatment of obesity (34.4%). A large majority supported treatment for lung cancer (86.1%), and a clear majority also supported treatment for COPD, whether it was framed as 'smoker's lung' (61.9%) or COPD (71.2%). The belief that lifestyle-related diseases are caused by the external environment or genetic disposition did not systematically influence support. Agreement that 'people lack responsibility for their life and welfare' reduced support significantly for all treatment types. However, in contrast with pulmonary diseases, support for publicly funded obesity treatments decreased considerably when beliefs about individual failure (that is that people lack 'willpower' and 'individual responsibility') were detected. CONCLUSIONS: Support for publicly funded COPD and lung cancer treatment is considerably higher than that for obesity treatment. This could encourage institutional discrimination through policies that involve charging patients for the treatment of obesity but not for the treatment of other lifestyle-related diseases.
BACKGROUND/ OBJECTIVES: This study examined public support for publicly funded treatment of obesity (weight-loss surgery and medical treatment) and two pulmonary diseases (chronic obstructive pulmonary disease (COPD) and lung cancer) in Denmark. It also investigated whether beliefs about the causes of lifestyle-related diseases (external environment, genetic disposition and lack of willpower) and agreement that 'people lack responsibility for their life and welfare' influenced support. SUBJECTS/ METHODS: This was a questionnaire study in which a sample of 1003 Danes (age 18-65 years) drawn from an Internet database were surveyed. RESULTS: Approximately one in three supported publicly funded weight-loss surgery (30%) and medical treatment of obesity (34.4%). A large majority supported treatment for lung cancer (86.1%), and a clear majority also supported treatment for COPD, whether it was framed as 'smoker's lung' (61.9%) or COPD (71.2%). The belief that lifestyle-related diseases are caused by the external environment or genetic disposition did not systematically influence support. Agreement that 'people lack responsibility for their life and welfare' reduced support significantly for all treatment types. However, in contrast with pulmonary diseases, support for publicly funded obesity treatments decreased considerably when beliefs about individual failure (that is that people lack 'willpower' and 'individual responsibility') were detected. CONCLUSIONS: Support for publicly funded COPD and lung cancer treatment is considerably higher than that for obesity treatment. This could encourage institutional discrimination through policies that involve charging patients for the treatment of obesity but not for the treatment of other lifestyle-related diseases.
Authors: Kari A O Tikkinen; Janne S Leinonen; Gordon H Guyatt; Shanil Ebrahim; Teppo L N Järvinen Journal: BMJ Open Date: 2012-12-02 Impact factor: 2.692
Authors: S Vallgårda; M E J Nielsen; A K K Hansen; K Ó Cathaoir; M Hartlev; L Holm; B J Christensen; J D Jensen; T I A Sørensen; P Sandøe Journal: Eur J Clin Nutr Date: 2017-09-27 Impact factor: 4.016
Authors: Franshelis K Garcia; Kirsten T Verkooijen; Esther J Veen; Bob C Mulder; Maria A Koelen; Eric J Hazebroek Journal: JMIR Res Protoc Date: 2022-04-28